Andy Batts
Long only, value, growth, momentum

Align Technology: Buy This Orthodontics Pioneer In The Corrective Phase

Align Technology (NASDAQ:ALGN) is a provider of a modern system - Invisalign, which corrects malocclusion or misalignment of teeth. The stock of the company has corrected ~10% from the recent high of $60. According to fellow Seeking Alpha contributor Arizona Trader, Danaher Corporation (NYSE:DHR) just sold out a major stake (4.6 million shares) in Align for $54.60. In the last one year the stock has appreciated ~100% due to the company's huge growth prospects. I strongly believe that the corrective phase in the stock is an excellent buying opportunity with ~25% upside potential over the next one year.

Company Overview

Align designs, manufactures and markets the Invisalign system, a proprietary method for treating malocclusion. A malocclusion

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details